Przewalskin is primarily studied for its potential anti-cancer properties, particularly in inhibiting the growth of certain tumor cells. It has shown activity in suppressing pathways involved in cell proliferation and survival, making it a subject of interest in oncology research. The compound may induce apoptosis in cancer cells and has been investigated for its effects on liver, breast, and lung cancer lines. Additionally, Przewalskin exhibits anti-inflammatory and antioxidant activities, which could contribute to its therapeutic potential in chronic diseases. Research is ongoing to evaluate its bioavailability and efficacy in preclinical models.